Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 6Neoplasms 2Uveal Melanoma 1Triple Negative Breast Neoplasms 1The Initial Aim of This Project is to Perform in Vitro Validation of Neoepitope Candidates Selected From Available Mutanome Data 1Skin Neoplasms 1Neoplasm Metastasis 1Healthy Adults 1Glioblastoma 1Eye Neoplasms 1Esophageal Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1Carcinoma 1Brain Neoplasms 1Biliary Tract Neoplasms 1

Interventions

Ipilimumab 6tremelimumab 5durvalumab 5Nivolumab 3Capecitabine 3Radiotherapy 2Radiation 2Paclitaxel 2CTLA-4 Antigen 2Blood Specimen Collection 2relatlimab 1poly ICLC 1lenvatinib 1folfirinox 1balstilimab 1Vaccines 1Vaccination 1Surgical Procedures, Operative 1Radiosurgery 1Platinum 1Peptides 1Pemetrexed 1Oxaliplatin 1Opdualag 1Monophenol Monooxygenase 1Melphalan 1Leucovorin 1Immunotherapy 1Fluorouracil 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Diabetes Mellitus, Insulin-Dependent, 12 × Peptides × Clear all
NCT06564623 2026-05-08

Targeting Driver Oncogenes With a Peptide Vaccine Plus Durvalumab and Tremelimumab for Patients With Biliary Tract Cancers (BTC)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1 Recruiting
25 enrolled
Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Biliary Tract Neoplasms, Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡